What is ACELYRIN, INC. Common Stock (SLRN) stock price today?

ACELYRIN, INC. Common Stock (SLRN) currently trades at $2.27 per share. The stock has a market capitalization of $229.17M and a P/E ratio of —x.

Is SLRN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, ACELYRIN, INC. Common Stock has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 5.71.

Is ACELYRIN, INC. Common Stock financially healthy?

ACELYRIN, INC. Common Stock's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 5.71 places it in the safe zone.

SLRN

ACELYRIN, INC. Common Stock

NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY

$2.27

+0.00% today

Updated 2026-04-30

Market cap

$229.17M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.69

Dividend yield

—

52W range

$2 – $3

Volume

4.1M

Market cap

$229.17M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.69

Dividend yield

—

52W range

$2 – $3

Volume

4.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

5.7

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$8.00

+252.42%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Altman Z 5.71 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-38.96M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-41.84M	$-250.46M	$-381.64M	$-248.23M	$-55.26M
EPS	—	—	—	—	$-2.69
Free cash flow	$-29.98M	$-61.52M	$-182.00M	$-305.17M	$-38.96M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLRN	$229.17M	32	4.3	3.0	5.0	8.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

ACELYRIN, INC. Common Stock trades at $2.27. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.71, it sits in the safe zone.

Frequently asked questions

What is ACELYRIN, INC. Common Stock's stock price?

ACELYRIN, INC. Common Stock (SLRN) trades at $2.27.

Is ACELYRIN, INC. Common Stock overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell).

What is the price target of ACELYRIN, INC. Common Stock (SLRN)?

The analyst target price is $8.00, representing +252.4% upside from the current price of $2.27.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

5.71 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-51.10%

Beta1.09

50D MA$2.40

200D MA$3.55

Shares out0.10B

Float0.07B

Short ratio—

Avg volume4.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SLRN vs LLY →SLRN vs JNJ →SLRN vs ABBV →Stock screener →